Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)-Reference-Cited by-同舟云学术

Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)

Published:2019-10-15 Issue:11 Volume:23 Page:943-954
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Verstockt Sare¹²^ORCID,Verstockt Bram²³^ORCID,Vermeire Séverine²³^ORCID

Affiliation:

1. KU Leuven Department of Human Genetics, Laboratory for Complex Genetics, Leuven, Belgium

2. KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium

3. Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1677608

Reference135 articles.

1. Crohn's disease

2. Ulcerative colitis

3. Diagnostic Delay in Crohn’s Disease: Time for Red Flags

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

2. Biomarkers for Personalizing IBD Therapy: The Quest Continues;Clinical Gastroenterology and Hepatology;2024-07

3. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond;Diagnostics;2024-06-28

4. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options;International Journal of Molecular Sciences;2024-06-27

5. Predicting the Long‐Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis;Clinical Pharmacology & Therapeutics;2024-03-19